Your browser doesn't support javascript.
loading
Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center.
Khan, Alesia; Woodley, Claire; Radia, Deepti; Mikhaeel, George N; Brady, Jessica; Garcia, Natalia Curto; Harrington, Patrick; O'Sullivan, Jennifer; Kordasti, Shahram; Francis, Yvonne; Asirvatham, Susan; Ali, Sahra; Sriskandarajah, Priya; Saunders, Jamie; de Lavallade, Hugues; McLornan, Donal P; Harrison, Claire N.
Afiliação
  • Khan A; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Woodley C; Department of Haematology, St. James' Hospital, Leeds, United Kingdom.
  • Radia D; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Mikhaeel GN; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Brady J; Department of Clinical Oncology, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Garcia NC; Department of Clinical Oncology, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Harrington P; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • O'Sullivan J; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Kordasti S; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Francis Y; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Asirvatham S; Comprehensive Cancer Centre, King's College London, London, United Kingdom.
  • Ali S; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Sriskandarajah P; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Saunders J; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • de Lavallade H; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • McLornan DP; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Harrison CN; Guy's International Centre of Excellence in Myeloid Disorders, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
Hemasphere ; 5(7): e611, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34235403
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Hemasphere Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Hemasphere Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido